Latest End-Stage Renal Disease (ESRD) News
Study finds no increased risk of major adverse cardiovascular events and death.
Every additional absent dorsalis pedis or posterior tibial pulse linked to increased risk of all outcomes.
Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease
End-stage renal disease is 32% more likely to develop in patients with C-reactive protein levels of 6.9 mg/L or higher vs 3.0 mg/L or lower.
Screening strategies are needed, as is further research on appropriate therapeutic approach.
In a study, 85.5% of advanced CKD patients opted for renal replacement therapy.
More than half of newly diagnosed ESRD patients visit the emergency department during their first year of treatment.
Major fractures included the proximal humerus, forearm, hip, and clinical vertebral fractures.
Data suggest primary GN is more likely than secondary GN to result in end-stage renal disease.
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
Only 40% of older patients transitioning to maintenance dialysis were on renin-angiotensin system blockade.
A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.
Researchers find an increased risk of death among patients.
High vs. low fitness levels in midlife lowered CKD risk in later life by 34%.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)